Martin MacKay

Martin MacKay

Founder presso RALLYBIO CORPORATION

Patrimonio netto: 4 M $ in data 31/03/2024

68 anni
Health Technology
Commercial Services
Technology Services

Profilo

Martin W.
MacKay
is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
21/03/2024 11 600 ( 0.02% ) 3 M $ 31/03/2024
15/02/2024 719 126 ( 1.90% ) 1 M $ 31/03/2024

Posizioni attive di Martin MacKay

SocietàPosizioneInizio
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director/Board Member 05/07/2017
NOVO NORDISK A/S Director/Board Member 01/03/2018
RALLYBIO CORPORATION Founder 01/01/2018
Director/Board Member -
Chief Executive Officer -
Chief Executive Officer 01/01/2018
Chief Executive Officer 22/12/2010
Tutte le posizioni attive di Martin MacKay

Precedenti posizioni note di Martin MacKay

SocietàPosizioneFine
501 ACQU Director/Board Member 22/04/2022
ALEXION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/06/2017
░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Martin MacKay

Formazione di Martin MacKay

The University of Edinburgh Doctorate Degree
Heriot-Watt University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Martin MacKay

Relazioni

100 +

Relazioni di 1° grado

28

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa6
PFIZER, INC.

Health Technology

ASTRAZENECA PLC

Health Technology

VERISIGN. INC.

Technology Services

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Commercial Services

NOVO NORDISK A/S

Health Technology

RALLYBIO CORPORATION

Health Technology

Aziende private20

Health Technology

Health Technology

Technology Services

Commercial Services

Communications

Process Industries

Technology Services

Finance

Health Technology

Commercial Services

Commercial Services

Technology Services

Commercial Services

Technology Services

Commercial Services

Ciba-Geigy Pharmaceuticals

Beecham Pharmaceuticals (UK)

Commercial Services

Health Services

Finance

Vedi le connessioni aziendali